UTime Limited (WTO)
NASDAQ: WTO · Real-Time Price · USD
0.9103
+0.0003 (0.03%)
Sep 3, 2025, 10:51 AM - Market open
UTime Revenue
In the fiscal year ending March 31, 2025, UTime had annual revenue of 251.00M CNY with 45.80% growth.
Revenue (ttm)
251.00M CNY
Revenue Growth
+54.01%
P/S Ratio
0.09
Revenue / Employee
2,535,323 CNY
Employees
99
Market Cap
3.28M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 251.00M | 78.84M | 45.80% |
Mar 31, 2024 | 172.16M | -25.41M | -12.86% |
Mar 31, 2023 | 197.56M | -77.94M | -28.29% |
Mar 31, 2022 | 275.51M | 28.61M | 11.59% |
Mar 31, 2021 | 246.90M | 53.81M | 27.87% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Apple | 408.63B |
Microsoft | 281.72B |
NVIDIA | 165.22B |
Taiwan Semiconductor Manufacturing Company | 116.30B |
Oracle | 57.40B |
Broadcom | 57.05B |
Cisco Systems | 56.65B |
SAP SE | 42.15B |
WTO News
- 12 days ago - UTime Ltd. Received Nasdaq Notification Letter Regarding Stockholders' Equity Deficiency - GlobeNewsWire
- 5 months ago - UTime Limited Announces 1-For-10 Reverse Share Split - GlobeNewsWire
- 11 months ago - UTime Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency - GlobeNewsWire
- 1 year ago - UTime Limited Announces Pricing of $5 Million Registered Direct Offering - GlobeNewsWire
- 1 year ago - UTime Limited Announces 1-For-25 Reverse Share Split - GlobeNewsWire
- 1 year ago - Remarkable Announcement on Significant Fluctuation of the UTime's Share Price - PRNewsWire
- 1 year ago - UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics - PRNewsWire
- 1 year ago - UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines - PRNewsWire